FDA’s ANDA Approvals
Executive Summary
Generic drug approvals and tentative approvals for late July.
You may also be interested in...
What’s Next? Five Things To Look Out For In March
In the month ahead, a key ANDA approval could come for Viatris, while additional competition to Gilead Sciences’ Truvada for PrEP is on the way in the US following Teva and Amneal’s launches.
Sensyne Algorithm For COVID-19 Risk Prediction Gets UK Regulatory Approval
Sensyne obtained UK regulatory approval for its SYNE-COV machine learning algorithm to assess the long-term risks of COVID-19.
Slovakia Becomes Second EU Country To OK Use Of Russian Vaccine
While the EU attempts to accelerate the pace of its unified approach to vaccine roll-out, some eastern European countries are taking their own decisions.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: